ArticleJournal of medical Internet research2025
Longitudinal Digital Phenotyping of Multiple Sclerosis Severity Using Passively Sensed Behaviors and Ecological Momentary Assessments: Real-World Evaluation.
Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Depression as a Disease of White Matter Network Disruption: Learning From Multiple Sclerosis.Biological psychiatry · 2026Review
- Plasmaphosphorylated tau as biomarkers for multiple sclerosis diagnosis, subtyping, and prognosis.Brain communications · 2026Article
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
backgroundLongitudinal tracking of multiple sclerosis (MS) symptoms in an individual's environment may improve self-monitoring and clinical management for people with MS. Conventional symptom tracking methods rely on self-reports and clinical visits, which can be infrequent, subjective, and burdensome. Digital phenotyping using passively collected sensor data from smartphones and fitness trackers offers a promising alternative for continuous, real-time symptom monitoring with minimal patient burden.
objectiveWe aimed to develop and evaluate a machine learning (ML)-based digital phenotyping approach to monitor the severity of clinically-relevant MS symptoms. We used passive sensing data to predict short-term fluctuations in patient-reported symptoms, including depressive symptoms, global MS symptom burden, severe fatigue, and poor sleep quality. Further, we examined the impact of incorporating behavioral context features and ecological momentary assessments on prediction performance.
methodsWe conducted a 12- to 24-week longitudinal study involving 104 people with MS, collecting passive sensor and behavioral health data. Smartphone sensors recorded call activity, location, and screen use, while fitness trackers captured heart rate, sleep patterns, and step count. We extracted patient-level behavioral features and categorized them into 2 feature sets: one from the prediction period (called action) and one from the preceding period (called context). Using an ML pipeline based on support vector machines and AdaBoost, we evaluated the predictive performance of sensor-based models, both with and without ecological momentary assessment inputs.
resultsBetween November 16, 2019, and January 24, 2021, overall, 104 people with MS (women: n=88, 84.6%; non-Hispanic White: n=97, 93.3%; mean age 44, SD 11.8 years) from a clinic-based cohort completed 12 weeks of data collection, including a subset of 44 participants (women: n=39, 89%; non-Hispanic White: n=42, 95%; mean age 45.7, SD 11.2 years) who completed 24 weeks of data collection. In total, we collected approximately 12,500 days of passive sensor and behavioral health data from the participants. Among the best-performing models with the least sensor data requirement, the ML algorithm predicted depressive symptoms with an accuracy of 80.6% (F
conclusionsOur digital phenotyping approach using passive sensors on smartphones and fitness trackers may help patients with real-world, continuous self-monitoring of common symptoms in their own environment and assist clinicians with better triage of patient needs for timely interventions in MS and potentially other chronic neurological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.